In the biotechnology and chemical spaces, genus claims are often sought by patent applicants to protect not only a specific product of interest, ...
Sanofi stock is surging with a Golden Cross formation and promising Dupixent results. With FDA review and potential approval, investors are excited.
Waterford's Sanofi hosts Vicky Phelan portrait tour for International Women's Day - News - Waterford News & Star ...
The boyfriend of slain Gqeberha mother Vicki Terblanche has been found guilty of her murder in the Eastern Cape High Court.
Attorney General Aaron M. Frey announced a settlement agreement with Sanofi-Aventis U.S. LLC after scrutiny over the ...
Under the settlement, Mainers who are uninsured or have commercial health insurance will be eligible to purchase monthly ...
As of March 11, 2025, three stocks in the health care sector could be flashing a real warning to investors who value momentum ...
Markets are tanking on tariff fears, inflationary concerns and now fears of recession. “Given this is so uncertain and that ...
Sanofi joins force with Samitivej International Children’s Hospital to launch the “Together Against RSV” awareness campaign in Thailand, with the support from the Pediatric Infectious Disease Society ...
One of the most highly anticipated FDA decisions this month is for Alnylam Pharmaceuticals, which is seeking to expand the ...
Regeneron Pharmaceuticals (REGN) and Sanofi (SNY) presented positive results from the pivotal ADEPT Phase 2/3 trial evaluating the ...
Five times more adults on Dupixent achieved sustained disease remission at 36 weeks compared to placebo; significant reductions were also seen in disease severity and itch Dupixent also significantly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results